Paul Knoepfler, a stem cell researcher at the UC Davis School of Medicine, has noted that this financial incentive may be diluted by the fact that potentially hundreds of thousands of people are already taking these peptides. So, the company would have to compete against unauthorized sources that havent invested anything into research
Misconception 2: A mechanism reported in animals will translate to humans
Regular checks are needed to adjust the treatment plan
Topical and Nasal AOD-9604 Topical and nasal forms appear in marketing, but the FDA review found no published human exposure data for transdermal or intranasal AOD-9604
caution in methylation disorders (use only under supervision) No known drug interactions with oral medications, but B12 may mask B9 (folate) deficiencycombined B-vitamin status should be assessed periodically
After 3 doses, its just now starting to work